Showing results (1311-1320 of 6,769) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|April 6, 2016
Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid ArthritisKeith A Betts, Jenny Griffith, Arijit Ganguli, et al.Clinical Therapeutics|April 6, 2016
Advances in Hereditary Colorectal and Pancreatic CancersMeghan L Underhill, Katharine A Germansky, Matthew B YurgelunClinical Therapeutics|April 12, 2016
Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male SubjectsShirin Bruderer, Kaori Okubo, Hideya Mukai, et al.Clinical Therapeutics|April 25, 2016
Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REGLars Rydén, Bahira Shahim, Linda MellbinClinical Therapeutics|April 18, 2016
Nanotube Formation: A Rapid Form of "Alarm Signaling"?Zuyi Weng, Bodi Zhang, Irene Tsilioni, et al.Clinical Therapeutics|April 18, 2016
Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard ChemotherapyChristopher N Graham, Gregory A Maglinte, Lee S Schwartzberg, et al.Clinical Therapeutics|April 11, 2016
Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort StudyChristopher B Chen, Mu Lin, Dean T Eurich, et al.Clinical Therapeutics|April 23, 2016
Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II StudyPanna Sanga, Elena Polverejan, Steven Wang, et al.Clinical Therapeutics|April 23, 2016
Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims DataNaonobu Sugiyama, Yutaka Kawahito, Takao Fujii, et al.Clinical Therapeutics|August 14, 2017
Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy SubjectsKyoung Lok Min, Min Soo Park, Jina Jung, et al.Pageof 677